Year archive

Sanofi — 2008 filings

All 53 regulatory filings released by Sanofi (SAN) in 2008, sourced directly from the official regulator.

53 Filings

2008 Period

2008 filings (53)

Filing	Released	Lang
Les résultats de l’étude DIONYSOS montrent les profils respectifs de la dronédarone et de l’amiodarone Regulatory Filings	2008-12-23	French
DIONYSOS Study Results Showed the Respective Profiles of Dronedarone and Amiodarone Regulatory Filings	2008-12-23	English
Sanofi-aventis et Novozymes annoncent une collaboration pour le développement et la commercialisation d’un antibiotique innovant Regulatory Filings	2008-12-22	French
Sanofi-aventis and Novozymes announce a development and commercialization collaboration for an innovative antibiotic Regulatory Filings	2008-12-22	English
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financier Regulatory Filings	2008-12-19	French
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement g Declaration of Voting Results & Voting Rights Announcements	2008-12-19	English
INTANZA®/IDflu® 1er vaccin intradermique contre la grippe recommandé dans l’Union Européenne Regulatory Filings	2008-12-18	French
INTANZA® / IDflu®, first intradermal influenza vaccine recommended in the European Union Earnings Release FY 2007	2008-12-18	English
Conseil d’administration du 17 décembre 2008 - Gouvernement d’entreprise - Remuneration Information	2008-12-18	French
Board of Directors dated December 17, 2008 - Corporate Governance - Governance Information	2008-12-18	English
FORM 6-K Foreign Filer Report	2008-12-15	English
Sanofi-aventis reçoit le « 2008 China Charity Award » du Ministère des Affaires Civiles de la République Populaire de Chine Environmental & Social Information	2008-12-15	French
Sanofi-aventis was granted the 2008 China Charity Award by the Ministry of Civil Affairs of the People’s Republic of China Environmental & Social Information	2008-12-15	English
Sanofi-aventis et Bristol-Myers Squibb gagnent l’appel dans le procès en contrefaçon Plavix aux Etats-Unis Legal Proceedings Report	2008-12-12	French
Sanofi-Aventis and Bristol-Myers Squibb prevail before the U.S. Court of Appeals for the Federal Circuit in the U.S Plavix® Patent infringement case Legal Proceedings Report	2008-12-12	English
Changements d’organisation Board/Management Information	2008-12-10	French
Changes in Organisation Board/Management Information	2008-12-10	English
FORM 6-K Foreign Filer Report	2008-12-03	English
Chris Viehbacher prend ses fonctions de Directeur Général du Groupe Board/Management Information	2008-12-01	French
Chris Viehbacher takes up his position as Chief Executive Officer Board/Management Information	2008-12-01	English
FORM 6-K Foreign Filer Report	2008-11-28	English
La FDA programme un « Advisory Committee » pour Multaq® (dronédarone), le 18 mars 2009 Regulatory Filings	2008-11-27	French
FDA intends to have an Advisory Committee meeting for Multaq® (dronedarone) on March 18, 2009 Regulatory Filings	2008-11-27	English
L’offre recommandée de Sanofi-aventis Europe sur Zentiva NV restera ouverte jusqu’au 20 février 2009 M&A Activity	2008-11-26	French
Sanofi-aventis Europe’s Recommended Offer for Zentiva To remain open until February 20, 2009 M&A Activity	2008-11-26	English
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financier Regulatory Filings	2008-11-26	French
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement g Declaration of Voting Results & Voting Rights Announcements	2008-11-26	English
Accords transactionnels aux Etats-Unis Legal Proceedings Report	2008-11-19	French
Settlement agreements in the U.S. Legal Proceedings Report	2008-11-19	English
La Russie choisit le vaccin polio inactivé de Sanofi Pasteur pour la primo-vaccination universelle des enfants Regulatory Filings	2008-11-12	French
Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of All Infants Regulatory Filings	2008-11-12	English
La dronédarone (Multaq®) a réduit l’incidence et la durée d’hospitalisation chez les patients atteints de fibrillation auriculaire Regulatory Filings	2008-11-11	French
Dronedarone (Multaq®) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation Regulatory Filings	2008-11-11	English
Sanofi Pasteur lance un vaccin pédiatrique au Japon, une première pour un producteur international de vaccins Regulatory Filings	2008-11-10	French
Sanofi Pasteur First International Vaccine Company to Enter Japan with Pediatric vaccine Regulatory Filings	2008-11-10	English
Publication dans l’American Heart Journal du plan de l’étude CURRENT-OASIS 7 Regulatory Filings	2008-11-06	French
Publication in the American Heart Journal of CURRENT-OASIS 7 Trial Design Regulatory Filings	2008-11-06	English
Sanofi-aventis arrête tous les essais cliniques sur rimonabant Regulatory Filings	2008-11-05	French
Sanofi-aventis to Discontinue all Clinical Trials with rimonabant Legal Proceedings Report	2008-11-05	English
RESULTATS DU TROISIEME TRIMESTRE 2008 Earnings Release 9M 2008	2008-10-31	French
THIRD-QUARTER 2008 RESULTS Earnings Release 9M 2008	2008-10-31	English
Nouvelles recommandations de l’ADA/EASD Regulatory Filings	2008-10-30	French
New ADA/EASD Treatment Recommendations Regulatory Filings	2008-10-30	English
La FDA approuve Apidra®, insuline à action rapide, pour le traitement des enfants diabétiques Earnings Release Q4 2008	2008-10-29	French
FDA Approves Rapid-Acting Insulin Apidra® for Treatment of Children with Diabetes Regulatory Filings	2008-10-29	English
Un vaccin contre la grippe fortement dosé augmente la réponse immunitaire chez les personnes de plus de 65 ans Earnings Release FY 2008	2008-10-26	French
High-Dose Influenza Vaccine Shows Increased Immune Response Among Adults 65 Years of Age and Older Earnings Release FY 2007	2008-10-26	English
Sanofi-aventis annonce, conformément à la recommandation de l’Agence Européenne du Médicament, la suspension temporaire de l’autorisation de mise sur le marché d’Acomplia® chez les patients obèses ou Regulatory Filings	2008-10-23	French
Sanofi-aventis is complying with the EMEA’s recommendation to temporarily suspend the marketing authorisation of Acomplia® in obese and overweight patients Earnings Release Q4 2008	2008-10-23	English
Accord entre sanofi-aventis et Medicines for Malaria Venture pour lutter contre le paludisme Regulatory Filings	2008-10-22	French
Sanofi-aventis and Medicines for Malaria Venture Enter Into Collaboration to Fight Malaria Regulatory Filings	2008-10-22	English
Sanofi-aventis renforce sa présence en Chine dans le domaine de la R&D Regulatory Filings	2008-10-21	French
Sanofi-aventis expands its R&D presence in China Regulatory Filings	2008-10-21	English

Filings by year

2026 123 filings
2025 367 filings
2024 220 filings
2023 220 filings
2022 253 filings
2021 243 filings
2020 234 filings
2019 261 filings
2018 221 filings
2017 245 filings
2016 270 filings
2015 188 filings
2014 229 filings
2013 229 filings
2012 210 filings
2011 300 filings
2010 256 filings
2009 270 filings
2008 53 filings
2004 6 filings
2003 1 filing
2002 1 filing
2000 1 filing